Galectin-1 may promote NRP-1 expression by activating IL-8 secretion, and then galectin-1 binds to NRP-1 that is highly expressed on the surface of CAFs or PSC, ultimately promoting PDAC tumor immune evasion. The gene discussed is CXCL8; the disease is neoplasm.